Langenbeck's Archives of Surgery

, Volume 394, Issue 5, pp 765–784 | Cite as

Imaging for primary hyperparathyroidism—an evidence-based analysis

Current Concepts in Endocrine Surgery

Abstract

Objective

Imaging in patients with primary hyperparathyroidism has been proven difficult. During the last decade, sestamibi scintigraphy and ultrasound (US) have been used with various success. The importance of these procedures has risen since minimal invasive parathyroid (MIP) surgery also has developed, and it is claimed that preoperative localization usually is needed before embarking on such a procedure.

Methods

We have scanned the most recent literature in this matter in order to identify evidence, using commonly accepted grading, and also concluded a number of recommendations.

Results and conclusions

We found evidence at level III leading to recommendations at grade B, that sestamibi scintigraphy is a recommended first test, but that US by an experienced investigator may be an alternative. MIP may be performed when both tests are concordant, and in case of only one test being positive, unilateral exploration and use of intraoperative PTH measurements are recommended. Bilateral neck exploration is used when both tests are negative. For reoperative procedures, repeat investigations are recommended, but also to use US-guided fine needle aspiration and PTH measurements as well as venous sampling. However, for reoperative procedures, the level of evidence is weaker—level IV, but recommendations still at grade B.

Keywords

Primary hyperparathyroidism Sestamibi scintigraphy Ultrasound Venous sampling Positron emission tomography Minimal invasive parathyroidectomy Intraoperative PTH Evidence-based analysis 

References

  1. 1.
    Research AfHCPa (1992) Acute pain management: operative or medical procedures and trauma. Clinical practice guide number I. Rockville, MD: AHCPRGoogle Scholar
  2. 2.
    Research AfHCa (1994) Management of cancer pain: adults. Clinical practice guideline number 9. Rockville, MD: AHCPRGoogle Scholar
  3. 3.
    Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996) Evidence based medicine: what it is and what it isn’t. BMJ 312:71–72PubMedGoogle Scholar
  4. 4.
    Druss B (2005) Evidence based medicine: does it make a difference? Use wisely. BMJ 330:92 discussion 94PubMedCrossRefGoogle Scholar
  5. 5.
    Moore A, Straube S, Derry S, McQuay H (2008) Does this work for you? Individuals, averages, and evidence based medicine. BMJ 337:a2585PubMedCrossRefGoogle Scholar
  6. 6.
    Tonelli MR (2006) Integrating evidence into clinical practice: an alternative to evidence-based approaches. J Eval Clin Pract 12:248–256PubMedCrossRefGoogle Scholar
  7. 7.
    Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE (1989) 99Tcm sestamibi—a new agent for parathyroid imaging. Nucl Med Commun 10:791–794PubMedCrossRefGoogle Scholar
  8. 8.
    Arbab AS, Koizumi K, Toyama K, Araki T (1996) Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 37:1551–1556PubMedGoogle Scholar
  9. 9.
    Hetrakul N, Civelek AC, Stagg CA, Udelsman R (2001) In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery 130:1011–1018PubMedCrossRefGoogle Scholar
  10. 10.
    O’Doherty MJ, Kettle AG, Wells P, Collins RE, Coakley AJ (1992) Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 33:313–318PubMedGoogle Scholar
  11. 11.
    Gotthardt M, Lohmann B, Behr TM, Bauhofer A, Franzius C, Schipper ML, Wagner M, Hoffken H, Sitter H, Rothmund M, Joseph K, Nies C (2004) Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg 28:100–107PubMedCrossRefGoogle Scholar
  12. 12.
    Stawicki SP, El Chaar M, Baillie DR, Jaik NP, Estrada FP (2007) Correlations between biochemical testing, pathology findings and preoperative sestamibi scans: a retrospective study of the minimally invasive radioguided parathyroidectomy (MIRP) approach. Nucl Med Rev Cent East Eur 10:82–86PubMedGoogle Scholar
  13. 13.
    Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP (2006) Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 30:697–704PubMedCrossRefGoogle Scholar
  14. 14.
    Parikshak M, Castillo ED, Conrad MF, Talpos GB (2003) Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism. Am Surg 69:393–398 discussion 399PubMedGoogle Scholar
  15. 15.
    Bandeira FA, Oliveira RI, Griz LH, Caldas G, Bandeira C (2008) Differences in accuracy of 99mTc-sestamibi scanning between severe and mild forms of primary hyperparathyroidism. J Nucl Med Technol 36:30–35PubMedCrossRefGoogle Scholar
  16. 16.
    Schachter PP, Issa N, Shimonov M, Czerniak A, Lorberboym M (2004) Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy. Arch Surg 139:433–437PubMedCrossRefGoogle Scholar
  17. 17.
    Calva-Cerqueira D, Smith BJ, Hostetler ML, Lal G, Menda Y, O’Dorisio TM, Howe JR (2007) Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH. J Am Coll Surg 205:S38–44PubMedCrossRefGoogle Scholar
  18. 18.
    Biertho LD, Kim C, Wu HS, Unger P, Inabnet WB (2004) Relationship between sestamibi uptake, parathyroid hormone assay, and nuclear morphology in primary hyperparathyroidism. J Am Coll Surg 199:229–233PubMedCrossRefGoogle Scholar
  19. 19.
    Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y, Sayek I, Gulec SA (2004) Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg 139:1175–1179PubMedCrossRefGoogle Scholar
  20. 20.
    Bhansali A, Masoodi SR, Bhadada S, Mittal BR, Behra A, Singh P (2006) Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: comparison with radionuclide scintigraphy and surgery. Clin Endocrinol (Oxf) 65:340–345CrossRefGoogle Scholar
  21. 21.
    Neumann DR, Obuchowski NA, Difilippo FP (2008) Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med 49:2012–2017PubMedCrossRefGoogle Scholar
  22. 22.
    Nichols KJ, Tomas MB, Tronco GG, Rini JN, Kunjummen BD, Heller KS, Sznyter LA, Palestro CJ (2008) Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings. Radiology 248:221–232PubMedCrossRefGoogle Scholar
  23. 23.
    Hung GU, Wang SJ, Lin WY (2003) Tc-99m MIBI parathyroid scintigraphy and intact parathyroid hormone levels in hyperparathyroidism. Clin Nucl Med 28:180–185PubMedCrossRefGoogle Scholar
  24. 24.
    Siegel A, Alvarado M, Barth RJ Jr, Brady M, Lewis J (2006) Parameters in the prediction of the sensitivity of parathyroid scanning. Clin Nucl Med 31:679–682PubMedCrossRefGoogle Scholar
  25. 25.
    Kandil E, Tufaro AP, Carson KA, Lin F, Somervell H, Farrag T, Dackiw A, Zeiger M, Tufano RP (2008) Correlation of plasma 25-hydroxyvitamin D levels with severity of primary hyperparathyroidism and likelihood of parathyroid adenoma localization on sestamibi scan. Arch Otolaryngol Head Neck Surg 134:1071–1075PubMedCrossRefGoogle Scholar
  26. 26.
    Schmidt M, Thoma N, Dietlein M, Moka D, Eschner W, Faust M, Schroder W, von Hulst-Schlabrendorff M, Ehses W, Schicha H (2008) 99mTc-MIBI SPECT in primary hyperparathyroidism. Influence of concomitant vitamin D deficiency for visualization of parathyroid adenomas. Nuklearmedizin 47:1–7PubMedGoogle Scholar
  27. 27.
    Friedman K, Somervell H, Patel P, Melton GB, Garrett-Mayer E, Dackiw AP, Civelek AC, Zeiger MA (2004) Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism. Surgery 136:1199–1204PubMedCrossRefGoogle Scholar
  28. 28.
    Erbil Y, Kapran Y, Issever H, Barbaros U, Adalet I, Dizdaroglu F, Bozbora A, Ozarmagan S, Tezelman S (2008) The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg 195:34–39PubMedCrossRefGoogle Scholar
  29. 29.
    Mehta NY, Ruda JM, Kapadia S, Boyer PJ, Hollenbeak CS, Stack BC Jr (2005) Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue. Arch Otolaryngol Head Neck Surg 131:493–498PubMedCrossRefGoogle Scholar
  30. 30.
    Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD, Hodin RA (2007) Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg 142:381–386PubMedCrossRefGoogle Scholar
  31. 31.
    Gupta Y, Ahmed R, Happerfield L, Pinder SE, Balan KK, Wishart GC (2007) P-glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidism. Br J Surg 94:1491–1495PubMedCrossRefGoogle Scholar
  32. 32.
    Katz SC, Wang GJ, Kramer EL, Roses DF (2003) Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease. Am Surg 69:170–175PubMedGoogle Scholar
  33. 33.
    Haciyanli M, Lal G, Morita E, Duh QY, Kebebew E, Clark OH (2003) Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 197:739–746PubMedCrossRefGoogle Scholar
  34. 34.
    Merlino JI, Ko K, Minotti A, McHenry CR (2003) The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings. Am Surg 69:225–229 discussion 229-230PubMedGoogle Scholar
  35. 35.
    Chiu B, Sturgeon C, Angelos P (2006) What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy. Surgery 140:418–422PubMedCrossRefGoogle Scholar
  36. 36.
    Erbil Y, Barbaros U, Yanik BT, Salmaslioglu A, Tunaci M, Adalet I, Bozbora A, Ozarmagan S (2006) Impact of gland morphology and concomitant thyroid nodules on preoperative localization of parathyroid adenomas. Laryngoscope 116:580–585PubMedCrossRefGoogle Scholar
  37. 37.
    Erbil Y, Barbaros U, Tukenmez M, Issever H, Salmaslioglu A, Adalet I, Ozarmagan S, Tezelman S (2008) Impact of adenoma weight and ectopic location of parathyroid adenoma on localization study results. World J Surg 32:566–571PubMedCrossRefGoogle Scholar
  38. 38.
    Sukan A, Reyhan M, Aydin M, Yapar AF, Sert Y, Canpolat T, Aktas A (2008) Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med 22:123–131PubMedCrossRefGoogle Scholar
  39. 39.
    Barczynski M, Golkowski F, Konturek A, Buziak-Bereza M, Cichon S, Hubalewska-Dydejczyk A, Huszno B, Szybinski Z (2006) Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas and in directing surgical approach. Clin Endocrinol (Oxf) 65:106–113CrossRefGoogle Scholar
  40. 40.
    Moure D, Larranaga E, Dominguez-Gadea L, Luque-Ramirez M, Nattero L, Gomez-Pan A, Marazuela M (2008) 99MTc-sestamibi as sole technique in selection of primary hyperparathyroidism patients for unilateral neck exploration. Surgery 144:454–459PubMedCrossRefGoogle Scholar
  41. 41.
    Siperstein A, Berber E, Barbosa GF, Tsinberg M, Greene AB, Mitchell J, Milas M (2008) Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 248:420–428PubMedGoogle Scholar
  42. 42.
    Royal RE, Delpassand ES, Shapiro SE, Fritsche HA Jr, Vassilopoulou-Sellin R, Sherman SI, Gagel RF, Evans DB, Lee JE (2002) Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression. Surgery 132:968–974 discussion 974-965PubMedCrossRefGoogle Scholar
  43. 43.
    Ogard CG, Vestergaard H, Thomsen JB, Jakobsen H, Almdal T, Nielsen SL (2005) Parathyroid scintigraphy during hypocalcaemia in primary hyperparathyroidism. Clin Physiol Funct Imaging 25:166–170PubMedCrossRefGoogle Scholar
  44. 44.
    Karam M, Dansereau RN, Dolce CJ, Feustel PJ, Robinson LW (2005) Increasing the radiochemical purity of 99mTc sestamibi commercial preparations results in improved sensitivity of dual-phase planar parathyroid scintigraphy. Nucl Med Commun 26:1093–1098PubMedCrossRefGoogle Scholar
  45. 45.
    Goetze S, Lavely WC, Ziessman HA, Wahl RL (2008) Visualization of brown adipose tissue with 99mTc-methoxyisobutylisonitrile on SPECT/CT. J Nucl Med 49:752–756PubMedCrossRefGoogle Scholar
  46. 46.
    Wong KK, Brown RK, Avram AM (2008) Potential false positive Tc-99m sestamibi parathyroid study due to uptake in brown adipose tissue. Clin Nucl Med 33:346–348PubMedCrossRefGoogle Scholar
  47. 47.
    Siegel A, Mancuso M, Seltzer M (2007) The spectrum of positive scan patterns in parathyroid scintigraphy. Clin Nucl Med 32:770–774PubMedCrossRefGoogle Scholar
  48. 48.
    Yip L, Pryma DA, Yim JH, Virji MA, Carty SE, Ogilvie JB (2008) Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism? World J Surg 32:784–792 discussion 793-784PubMedCrossRefGoogle Scholar
  49. 49.
    Kraas J, Clark PB, Perrier ND, Morton KA (2005) The scintigraphic appearance of subcapsular parathyroid adenomas. Clin Nucl Med 30:213–217PubMedCrossRefGoogle Scholar
  50. 50.
    Melton GB, Somervell H, Friedman KP, Zeiger MA, Cahid Civelek A (2005) Interpretation of 99mTc sestamibi parathyroid SPECT scan is improved when read by the surgeon and nuclear medicine physician together. Nucl Med Commun 26:633–638PubMedCrossRefGoogle Scholar
  51. 51.
    Kebebew E, Hwang J, Reiff E, Duh QY, Clark OH (2006) Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg 141:777–782 discussion 782PubMedCrossRefGoogle Scholar
  52. 52.
    Freudenberg LS, Frilling A, Sheu SY, Gorges R (2006) Optimizing preoperative imaging in primary hyperparathyroidism. Langenbecks Arch Surg 391:551–556PubMedCrossRefGoogle Scholar
  53. 53.
    Ansquer C, Mirallie E, Carlier T, Abbey-Huguenin H, Aubron F, Kraeber-Bodere F (2008) Preoperative localization of parathyroid lesions. Value of 99mTc-MIBI tomography and factors influencing detection. Nuklearmedizin 47:158–162PubMedGoogle Scholar
  54. 54.
    Arveschoug AK, Bertelsen H, Vammen B, Brochner-Mortensen J (2007) Preoperative dual-phase parathyroid imaging with tc-99m-sestamibi: accuracy and reproducibility of the pinhole collimator with and without oblique images. Clin Nucl Med 32:9–12PubMedCrossRefGoogle Scholar
  55. 55.
    Gilat H, Cohen M, Feinmesser R, Benzion J, Shvero J, Segal K, Ulanovsky D, Shpitzer T (2005) Minimally invasive procedure for resection of a parathyroid adenoma: the role of preoperative high-resolution ultrasonography. J Clin Ultrasound 33:283–287PubMedCrossRefGoogle Scholar
  56. 56.
    Kebapci M, Entok E, Kebapci N, Adapinar B (2004) Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy. J Endocrinol Invest 27:24–30PubMedGoogle Scholar
  57. 57.
    Solorzano CC, Lee TM, Ramirez MC, Carneiro DM, Irvin GL (2005) Surgeon-performed ultrasound improves localization of abnormal parathyroid glands. Am Surg 71:557–562 discussion 562-553PubMedGoogle Scholar
  58. 58.
    Soon PS, Delbridge LW, Sywak MS, Barraclough BM, Edhouse P, Sidhu SB (2008) Surgeon performed ultrasound facilitates minimally invasive parathyroidectomy by the focused lateral mini-incision approach. World J Surg 32:766–771PubMedCrossRefGoogle Scholar
  59. 59.
    Livingston CD, Victor B, Askew R, Abikhalid J, Meynig J, Lindsey M, Jones L (2008) Surgeon-performed ultrasonography as an adjunct to minimally invasive radio-guided parathyroidectomy in 100 consecutive patients with primary hyperparathyroidism. Endocr Pract 14:28–32PubMedGoogle Scholar
  60. 60.
    Solorzano CC, Carneiro-Pla DM, Irvin GL 3rd (2006) Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg 202:18–24PubMedCrossRefGoogle Scholar
  61. 61.
    Erbil Y, Barbaros U, Salmaslioglu A, Tunaci M, Ozbey N, Bozbora A, Ozmarmagan S (2006) Value of parathyroid hormone assay for preoperative sonographically guided parathyroid aspirates for minimally invasive parathyroidectomy. J Clin Ultrasound 34:425–429PubMedCrossRefGoogle Scholar
  62. 62.
    Maser C, Donovan P, Santos F, Donabedian R, Rinder C, Scoutt L, Udelsman R (2006) Sonographically guided fine needle aspiration with rapid parathyroid hormone assay. Ann Surg Oncol 13:1690–1695PubMedCrossRefGoogle Scholar
  63. 63.
    Kiblut NK, Cussac JF, Soudan B, Farrell SG, Armstrong JA, Arnalsteen L, Biechlin A, Delattre AA, Proye CA (2004) Fine needle aspiration and intraparathyroid intact parathyroid hormone measurement for reoperative parathyroid surgery. World J Surg 28:1143–1147PubMedCrossRefGoogle Scholar
  64. 64.
    Boudreaux BA, Magnuson JS, Asher SA, Desmond R, Peters GE (2007) The role of ultrasonography in parathyroid surgery. Arch Otolaryngol Head Neck Surg 133:1240–1244PubMedCrossRefGoogle Scholar
  65. 65.
    Lo CY, Lang BH, Chan WF, Kung AW, Lam KS (2007) A prospective evaluation of preoperative localization by technetium-99m sestamibi scintigraphy and ultrasonography in primary hyperparathyroidism. Am J Surg 193:155–159PubMedCrossRefGoogle Scholar
  66. 66.
    Prasannan S, Davies G, Bochner M, Kollias J, Malycha P (2007) Minimally invasive parathyroidectomy using surgeon-performed ultrasound and sestamibi. ANZ J Surg 77:774–777PubMedCrossRefGoogle Scholar
  67. 67.
    Prager G, Czerny C, Ofluoglu S, Kurtaran A, Passler C, Kaczirek K, Scheuba C, Niederle B (2003) Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg 196:541–548PubMedCrossRefGoogle Scholar
  68. 68.
    Zald PB, Hamilton BE, Larsen ML, Cohen JI (2008) The role of computed tomography for localization of parathyroid adenomas. Laryngoscope 118:1405–1410PubMedCrossRefGoogle Scholar
  69. 69.
    Lumachi F, Tregnaghi A, Zucchetta P, Marzola MC, Cecchin D, Marchesi P, Fallo F, Bui F (2004) Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study. Br J Radiol 77:100–103PubMedCrossRefGoogle Scholar
  70. 70.
    Kaczirek K, Prager G, Kienast O, Dobrozemsky G, Dudczak R, Niederle B, Kurtaran A (2003) Combined transmission and (99m)Tc-sestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmedizin 42:220–223PubMedGoogle Scholar
  71. 71.
    Profanter C, Wetscher GJ, Gabriel M, Sauper T, Rieger M, Kovacs P, Bale R, Prommegger R (2004) CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyperparathyroidism. Surgery 135:157–162PubMedCrossRefGoogle Scholar
  72. 72.
    Profanter C, Prommegger R, Gabriel M, Moncayo R, Wetscher GJ, Lang T, Bale R (2004) Computed axial tomography-MIBI image fusion for preoperative localization in primary hyperparathyroidism. Am J Surg 187:383–387PubMedCrossRefGoogle Scholar
  73. 73.
    Rodgers SE, Hunter GJ, Hamberg LM, Schellingerhout D, Doherty DB, Ayers GD, Shapiro SE, Edeiken BS, Truong MT, Evans DB, Lee JE, Perrier ND (2006) Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 140:932–940 discussion 940-931PubMedCrossRefGoogle Scholar
  74. 74.
    Wakamatsu H, Noguchi S, Yamashita H, Tamura S, Jinnouchi S, Nagamachi S, Futami S (2001) Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US. Eur J Nucl Med 28:1817–1827PubMedCrossRefGoogle Scholar
  75. 75.
    Ruf J, Lopez Hanninen E, Steinmuller T, Rohlfing T, Bertram H, Gutberlet M, Lemke AJ, Felix R, Amthauer H (2004) Preoperative localization of parathyroid glands. Use of MRI, scintigraphy, and image fusion. Nuklearmedizin 43:85–90PubMedGoogle Scholar
  76. 76.
    Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N (1998) Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 39:320–324PubMedGoogle Scholar
  77. 77.
    Neumann DR, Esselstyn CB, Maclntyre WJ, Go RT, Obuchowski NA, Chen EQ, Licata AA (1996) Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 37:1809–1815PubMedGoogle Scholar
  78. 78.
    Melon P, Luxen A, Hamoir E, Meurisse M (1995) Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med 22:556–558PubMedGoogle Scholar
  79. 79.
    Hellman P, Ahlstrom H, Bergstrom M, Sundin A, Langstrom B, Westerberg G, Juhlin C, Akerstrom G, Rastad J (1994) Positron emission tomography with 11C-methionine in hyperparathyroidism. Surgery 116:974–981PubMedGoogle Scholar
  80. 80.
    Sundin A, Johansson C, Hellman P, Bergstrom M, Ahlstrom H, Jacobson GB, Langstrom B, Rastad J (1996) PET and parathyroid l-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med 37:1766–1770PubMedGoogle Scholar
  81. 81.
    Beggs AD, Hain SF (2005) Localization of parathyroid adenomas using 11C-methionine positron emission tomography. Nucl Med Commun 26:133–136PubMedCrossRefGoogle Scholar
  82. 82.
    Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, Scheumann GF, Knapp WH (2004) Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging 31:1405–1412PubMedCrossRefGoogle Scholar
  83. 83.
    Tang BN, Moreno-Reyes R, Blocklet D, Corvilain B, Cappello M, Delpierre I, Devuyst F, Van Simaeys G, Goldman S (2008) Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging 3:157–163PubMedCrossRefGoogle Scholar
  84. 84.
    Lange-Nolde A, Zajic T, Slawik M, Brink I, Reincke M, Moser E, Hoegerle S (2006) PET with 18F-DOPA in the imaging of parathyroid adenoma in patients with primary hyperparathyroidism. A pilot study. Nuklearmedizin 45:193–196PubMedGoogle Scholar
  85. 85.
    Estella E, Leong MS, Bennett I, Hartley L, Wetzig N, Archibald CA, Harper JS, Cuneo RC (2003) Parathyroid hormone venous sampling prior to reoperation for primary hyperparathyroidism. ANZ J Surg 73:800–805PubMedCrossRefGoogle Scholar
  86. 86.
    Jones JJ, Brunaud L, Dowd CF, Duh QY, Morita E, Clark OH (2002) Accuracy of selective venous sampling for intact parathyroid hormone in difficult patients with recurrent or persistent hyperparathyroidism. Surgery 132:944–950 discussion 950-941PubMedCrossRefGoogle Scholar
  87. 87.
    Udelsman R, Aruny JE, Donovan PI, Sokoll LJ, Santos F, Donabedian R, Venbrux AC (2003) Rapid parathyroid hormone analysis during venous localization. Ann Surg 237:714–719 discussion 719-721PubMedCrossRefGoogle Scholar
  88. 88.
    Chaffanjon PC, Voirin D, Vasdev A, Chabre O, Kenyon NM, Brichon PY (2004) Selective venous sampling in recurrent and persistent hyperparathyroidism: indication, technique, and results. World J Surg 28:958–961PubMedCrossRefGoogle Scholar
  89. 89.
    Eloy JA, Mitty H, Genden EM (2006) Preoperative selective venous sampling for nonlocalizing parathyroid adenomas. Thyroid 16:787–790PubMedCrossRefGoogle Scholar
  90. 90.
    Hessman O, Stalberg P, Sundin A, Garske U, Rudberg C, Eriksson LG, Hellman P, Akerstrom G (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32:774–781 discussion 782-773PubMedCrossRefGoogle Scholar
  91. 91.
    Liew V, Gough IR, Nolan G, Fryar B (2004) Re-operation for hyperparathyroidism. ANZ J Surg 74:732–740PubMedCrossRefGoogle Scholar
  92. 92.
    Reidel MA, Schilling T, Graf S, Hinz U, Nawroth P, Buchler MW, Weber T (2006) Localization of hyperfunctioning parathyroid glands by selective venous sampling in reoperation for primary or secondary hyperparathyroidism. Surgery 140:907–913 discussion 913PubMedCrossRefGoogle Scholar
  93. 93.
    Ito F, Sippel R, Lederman J, Chen H (2007) The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 245:959–963PubMedCrossRefGoogle Scholar
  94. 94.
    Udelsman R, Donovan PI (2006) Remedial parathyroid surgery: changing trends in 130 consecutive cases. Ann Surg 244:471–479PubMedGoogle Scholar
  95. 95.
    Richards ML, Thompson GB, Farley DR, Grant CS (2008) Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring. Am J Surg 196:937–942 discussion 942-933PubMedCrossRefGoogle Scholar
  96. 96.
    Yen TW, Wang TS, Doffek KM, Krzywda EA, Wilson SD (2008) Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach. Surgery 144:611–619 discussion 619-621PubMedCrossRefGoogle Scholar
  97. 97.
    Civelek AC, Ozalp E, Donovan P, Udelsman R (2002) Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery 131:149–157PubMedCrossRefGoogle Scholar
  98. 98.
    Peters G, Kulbersh B, Mantle B, Bell W, Grizzle W, Rosenthal E (2007) Role of microvascular density in nonlocalizing parathyroid sestamibi scans. Laryngoscope 117:2163–2168PubMedCrossRefGoogle Scholar
  99. 99.
    Rodriguez-Carranza S, Caceres M, Aguilar-Salinas CA, Gomez-Perez FJ, Herrera MF, Pantoja JP, Rull JA (2004) Localization of parathyroid adenomas by (99m)Tc-sestamibi scanning: upper neck versus lower neck lesions. Endocr Pract 10:472–477PubMedGoogle Scholar
  100. 100.
    Goldstein RE, Billheimer D, Martin WH, Richards K (2003) Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg 237:722–730 discussion 730-721PubMedCrossRefGoogle Scholar
  101. 101.
    Alexandrides TK, Kouloubi K, Vagenakis AG, Yarmenitis S, Spyridonidis T, Vassilakos P, Apostolopoulos D (2006) The value of scintigraphy and ultrasonography in the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism and concomitant thyroid disease. Hormones (Athens) 5:42–51Google Scholar
  102. 102.
    Scheiner JD, Dupuy DE, Monchik JM, Noto RB, Cronan JJ (2001) Pre-operative localization of parathyroid adenomas: a comparison of power and colour Doppler ultrasonography with nuclear medicine scintigraphy. Clin Radiol 56:984–988PubMedCrossRefGoogle Scholar
  103. 103.
    De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L, Borrelli D, Cicchi P, Tonelli F, Amorosi A, Serio M, Brandi ML (2000) Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 214:393–402PubMedGoogle Scholar
  104. 104.
    Clark PB, Case D, Watson NE, Morton KA, Perrier ND (2003) Experienced scintigraphers contribute to success of minimally invasive parathyroidectomy by skilled endocrine surgeons. Am Surg 69:478–483 discussion 483-474PubMedGoogle Scholar
  105. 105.
    Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P (2003) Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 44:904–908PubMedGoogle Scholar
  106. 106.
    Spanu A, Falchi A, Manca A, Marongiu P, Cossu A, Pisu N, Chessa F, Nuvoli S, Madeddu G (2004) The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med 45:40–48PubMedGoogle Scholar
  107. 107.
    Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, Ochoa BB, Moxley DM, Erwin WD, Podoloff DA (2005) The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 46:248–252PubMedGoogle Scholar
  108. 108.
    Pappu S, Donovan P, Cheng D, Udelsman R (2005) Sestamibi scans are not all created equally. Arch Surg 140:383–386PubMedCrossRefGoogle Scholar
  109. 109.
    Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R, Even-Sapir E, Chisin R, Israel O (2006) Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg 30:76–83PubMedCrossRefGoogle Scholar
  110. 110.
    Rasmussen K, Larsen LP, Arveschoug A, Theil Nielsen J, Vestergaard P, Ronning H, Mosekilde L, Christiansen P (2006) Predictive value of parathyroid scintigraphy in the preoperative evaluation of patients with primary hyperparathyroidism. Scand J Surg 95:199–204PubMedGoogle Scholar
  111. 111.
    Sharma J, Mazzaglia P, Milas M, Berber E, Schuster DM, Halkar R, Siperstein A, Weber CJ (2006) Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality? Surgery 140:856–863 discussion 863-855PubMedCrossRefGoogle Scholar
  112. 112.
    Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, Dackiw AP, Tufano RP, Zeiger MA, Ziessman HA (2007) Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med 48:1084–1089PubMedCrossRefGoogle Scholar
  113. 113.
    Ruf J, Seehofer D, Denecke T, Stelter L, Rayes N, Felix R, Amthauer H (2007) Impact of image fusion and attenuation correction by SPECT-CT on the scintigraphic detection of parathyroid adenomas. Nuklearmedizin 46:15–21PubMedGoogle Scholar
  114. 114.
    Carlier T, Oudoux A, Mirallie E, Seret A, Daumy I, Leux C, Bodet-Milin C, Kraeber-Bodere F, Ansquer C (2008) 99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography. Eur J Nucl Med Mol Imaging 35:637–643PubMedCrossRefGoogle Scholar
  115. 115.
    Del Rio P, Cataldo S, Sommaruga L, Arcuri MF, Massa M, Sianesi M (2008) Localization of pathological gland’s site in primary hyperparathyroidism: ten years experience with MIBI scintigraphy. G Chir 29:186–189PubMedGoogle Scholar
  116. 116.
    Harris L, Yoo J, Driedger A, Fung K, Franklin J, Gray D, Holliday R (2008) Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intraoperative anatomical location of parathyroid adenomas. Head Neck 30:509–517PubMedCrossRefGoogle Scholar
  117. 117.
    Ho Shon IA, Yan W, Roach PJ, Bernard EJ, Shields M, Sywak M, Sidhu S, Delbridge LW (2008) Comparison of pinhole and SPECT 99mTc-MIBI imaging in primary hyperparathyroidism. Nucl Med Commun 29:949–955PubMedCrossRefGoogle Scholar
  118. 118.
    Tomas MB, Pugliese PV, Tronco GG, Love C, Palestro CJ, Nichols KJ (2008) Pinhole versus parallel-hole collimators for parathyroid imaging: an intraindividual comparison. J Nucl Med Technol 36:189–194PubMedCrossRefGoogle Scholar
  119. 119.
    Mortenson MM, Evans DB, Lee JE, Hunter GJ, Shellingerhout D, Vu T, Edeiken BS, Feng L, Perrier ND (2008) Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg 206:888–895 discussion 895-886PubMedCrossRefGoogle Scholar
  120. 120.
    Ogilvie CM, Brown PL, Matson M, Dacie J, Reznek RH, Britton K, Carpenter R, Berney D, Drake WM, Jenkins PJ, Chew SL, Monson JP (2006) Selective parathyroid venous sampling in patients with complicated hyperparathyroidism. Eur J Endocrinol 155:813–821PubMedCrossRefGoogle Scholar
  121. 121.
    Lumachi F, Ermani M, Basso S, Zucchetta P, Borsato N, Favia G (2001) Localization of parathyroid tumours in the minimally invasive era: which technique should be chosen? Population-based analysis of 253 patients undergoing parathyroidectomy and factors affecting parathyroid gland detection. Endocr Relat Cancer 8:63–69PubMedCrossRefGoogle Scholar
  122. 122.
    Wakamatsu H, Noguchi S, Yamashita H, Tamura S, Jinnouchi S, Nagamachi S, Futami S (2003) Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl Med Commun 24:755–762PubMedCrossRefGoogle Scholar
  123. 123.
    Lopez Hanninen E, Vogl TJ, Steinmuller T, Ricke J, Neuhaus P, Felix R (2000) Preoperative contrast-enhanced MRI of the parathyroid glands in hyperparathyroidism. Invest Radiol 35:426–430PubMedCrossRefGoogle Scholar
  124. 124.
    Haber RS, Kim CK, Inabnet WB (2002) Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy. Clin Endocrinol (Oxf) 57:241–249CrossRefGoogle Scholar
  125. 125.
    Lumachi F, Marzola MC, Zucchetta P, Tregnaghi A, Cecchin D, Bui F (2003) Hyperfunctioning parathyroid tumours in patients with thyroid nodules. Sensitivity and positive predictive value of high-resolution ultrasonography and 99mTc-sestamibi scintigraphy. Endocr Relat Cancer 10:419–423PubMedCrossRefGoogle Scholar
  126. 126.
    Grosso I, Sargiotto A, D’Amelio P, Tamone C, Gasparri G, De Filippi PG, Picciotto G, Isaia G (2007) Preoperative localization of parathyroid adenoma with sonography and 99mTc-sestamibi scintigraphy in primary hyperparathyroidism. J Clin Ultrasound 35:186–190PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Department of SurgeryJohn Radcliffe HospitalOxfordUK
  2. 2.Department of SurgeryBethesda HospitalDuisburgGermany
  3. 3.Department of SurgeryUniversity HospitalUppsalaSweden

Personalised recommendations